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Abstract
Background: Cell-specific expression of the gene that encodes brain-derived neurotrophic factor
(BDNF) is required for the normal development of peripheral sensory neurons and efficient
synaptic transmission in the mature central and peripheral nervous system. The control of BDNF
gene expression involves multiple tissue and cell-specific promoters that are differentially regulated.
The molecular mechanisms that are responsible for tissue and cell-specific expression of these
promoters are still incompletely understood.
Results: The cloning and analysis of three additional zebrafish (Danio rerio) BDNF gene exons and
two associated promoters, is reported. Among them are two exons that generate a novel tripartite
mature transcript. The exons were located on the transcription unit, whose overall organization
was determined by cloning, Southern blot hybridization and sequence analysis, and compared with
the pufferfish (Fugu rubripes) and mammalian BDNF loci, revealing a conserved but more compact
organization. Structural and functional analysis of the exons, their adjacent promoters and 5' flanks,
showed that they are expressed cell-specifically. The promoter associated with the 5' exon of the
tripartite transcript is GC-rich, TATA-less and the 5' flank adjacent to it contains multiple Sp1,
Mef2, and AP1 elements. A fusion gene containing the promoter and 1.5 KB of 5' flank is directed
exclusively to skeletal muscle of transiently transfected embryos. The second promoter, whose
associated 5' exon contains a 25-nucleotide segment of identity with a mammalian BDNF gene
exon, was transiently expressed in yolk of the early embryo. RT-PCR analysis of total RNA from
whole juvenile fish and adult female skeletal muscle revealed tissue-specific expression of the 5'
exons but the novel exon could not be detected even after two rounds of nested PCR.
Conclusion: The zebrafish BDNF gene is as complex as the mammalian gene yet much more
compact. Its exons are expressed in an independently regulated and cell-specific fashion. An initial
structural and functional analysis has shown that the regions controlling zebrafish BDNF gene
expression have been cloned and identified. They can now be subjected to detailed molecular and
genetic analyses to identify the cellular mechanisms by which the transcription factors that act on
these regions control BDNF gene expression.
Background
The neurotrophins play crucial functions in the interac-
tion of muscles with their innervating neurons during
development and in the adult vertebrate organism. The
neurotrophin family includes Nerve Growth Factor
(NGF), Neurotrophin-3 (NT-3), Neurotrophin-4/5 (NT-
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4/5), Neurotrophin-6 (NT6) and Brain-derived Neuro-
trophic Factor (BDNF). Three neurotrophins, BDNF, NT-
3, and NT-4/5 are known to contribute to the develop-
ment, maintenance, and functioning of the neuromuscu-
lar system. Each of these three neurotrophins is expressed
differentially in muscle during development, in the adult
and in response to injury. NT-3 is the most abundantly
expressed of the three neurotrophins during embryonic
muscle development, followed by NT-4/5 and BDNF
[1,2]. After birth, NT-3 and NT-4/5 are down-regulated in
muscle whereas BDNF continues to be expressed at low
levels [1]. BDNF mRNA is expressed in myocytes in the
adult muscle [3]. Essentially nothing is known about
BDNF gene expression in fish muscle. We detected BDNF
mRNA in the muscle layer of the fin of the 4 days old
zebrafish larvae using in situ hybridization [4], but the
identity of the expressing cells has not yet been definitvely
established.
The first demonstration that BDNF potentiates neuromus-
cular transmission was reported by Lohof AM, et al. [5].
BDNF transiently stabilizes silent NM synapses during the
period of transition from polyneuronal to mononeuronal
innervation of skeletal muscle fibers [6]. BDNF and CNTF
cooperatively affect efficiency of embryonic xenopus neu-
romuscular synapses in culture [7,8]. BDNF stimulates
transmitter release from neuromuscular synapses [9] and
enhances the efficiency of transmission at the neuromus-
cular synapse [10]. BDNF, together with NT-3, can restore
neuregulin levels and a normal distribution of AchR at the
neuromuscular junction blocked with curare [11]. BDNF,
in conjunction with fibronectin, increases spontaneous
synaptic currents in the cultured embryonic xenopus neu-
romuscular junction [12]. BDNF down-regulates AchR
clustering, most likely by binding to TrkB expressed in
myocytes [13]. BDNF downregulates agrin levels in mus-
cle but increases neuregulin in ventral horn spinal motor
neurons at the time when they form neuromuscular syn-
apses [14].
BDNF production is activity dependent [11,15] Muscle
activity is required to maintain BDNF mRNA levels in rat
soleus muscle [16,17]. Vigorous exercise increases BDNF
mRNA levels above baseline [17]. Neuromuscular block-
ade in culture also decreases BDNF mRNA levels. In
response to nerve injury BDNF mRNA is slowly but sub-
stantially increased in Schwann cells and muscle fibers
[18]. BDNF expression is also increased in cardiac myo-
cytes following ischemic injury [19].
The molecular mechanisms that induce BDNF gene
expression in muscle during development, maintain basal
expression in the adult muscle and dynamically regulate
BDNF mRNA in muscle in response to neuromuscular
activity and injury are not known. To understand the con-
tribution of BDNF gene transcription to this regulation we
have begun to examine the structure, organization, and
expression of the zebrafish BDNF gene. The mammalian
BDNF gene is known to have at least four promoters
whose cell-specific and developmental activity is differen-
tially regulated [20–26]. The transcripts derived from
these promoters have a common organization. They all
consist of two exons: one of the 5' non-coding exons fol-
lowed by the coding exon, which is common to all
transcripts.
We previously cloned a zebrafish BDNF transcript that
appeared to contain two exons and thus suggested that the
zebrafish and mammalian BDNF genes have similar
organizations [4]. We recently cloned the zebrafish BDNF
gene and identified the previously cloned 5' exon in the
genomic clone [27]. The exon was named exon 1c.
Sequence analysis confirmed that the position of the
intron that separates exon 1c from the common coding
exon is identical in fish and man. In addition, the size of
the intron is similar in fish and mouse. Exon 1c contains
a 39 bp sequence that is 93% identical to a segment in
exon III of the rat BDNF gene. Transient expression in
developing zebrafish embryos of the promoter upstream
from exon 1c using an EGFP-F reporter revealed expres-
sion in a number of cell types, including skeletal muscle,
epithelial cells, notochord, and vascular cells.
I here report the cloning, structural analysis, and tran-
scriptional activity in transiently transfected developing
zebrafish embryos of three additional 5' exons and their
associated promoters. Two of the 5' exons were found in
the same transcript. This transcript thus contains three
exons, a novel structure of a BDNF transcript not previ-
ously reported. These two exons could not be found by
homology searches in the mammalian genome but were
detected in the pufferfish genome. The promoter
upstream from the 5' exon of the tripartite transcript was
linked to the EGFP-F reporter. The fusion gene was exclu-
sively expressed in terminally differentiated myocytes of
developing zebrafish embryos. The 5' flank immediately
upstream from the promoter is GC-rich and contains mul-
tiple Sp1-like sequences as well as several potential Mef-2
binding sites. These transcription factors are known to be
important for the expression of genes in myocytes.
Although the endogenous exon and promoter were
expressed in embryonic muscle the endogenous exon
could not be detected in juvenile fish or adult female mus-
cle by RT-PCR. Possible explanations for this discrepancy
are discussed.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/11
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Results
The zebrafish BDNF gene has at least four 5' non-coding 
exons
The organization of all neurotrophin genes so far exam-
ined is similar [28,29]. It was therefore expected that the
zebrafish BDNF gene would have multiple 5' exons. To
identify additional 5' exons, 5' RACE was employed. To
maximize the chances of finding all existing exons total
RNA extracted from 10 days old larvae was used as the
template. The relative abundance of BDNF transcripts in
total RNA dramatically increases in the first 7 days of
development and plateaus by 10 days pf [4].
Initially, 48 of the 5' RACE clones were screened for inserts
by restriction enzyme digest (figure 1). To identify 5'
RACE clones that contained novel 5' non-coding exons
the nucleotide sequences of representatives of groups of
clones with similar sizes were determined. The sequences
were compared with the sequences of subclones of the
genomic BDNF clone c241 which we had previously iden-
tified and partially sequenced [27]. Five of the ten
sequenced 5' RACE clones contained the already known
and previously cloned 5' exon [4]. This exon was named
exon 1c because it contains a 39 nucleotide segment in
which 37 nucleotides are identical with a segment in rat
exon III, suggesting the two exons are orthologous (see
table 1 and figure 2a) [25].
Two clones contained 248 bp inserts. The first 53 nucle-
otides were found close to the 5' end of a 9 kb genomic
HindIII fragment of c241 that contains exon 1c close to its
centre [27]. The next 195 nucleotides were found 905
nucleotides downstream, suggesting that they represented
an internal exon. Classical splice acceptor and donor di-
nucleotides surround this 195 bp exon (see table 2 – 1),
consistent with an internal position in a BDNF transcript.
The shorter more 5' exon was named exon 1b, and the
more 3' exon exon 1b' (see figure 2).
All known BDNF gene 5' exons are directly spliced to the
common coding exon, generating mature messages that
contain two exons, a single 5' non-coding and the com-
mon coding exon. Finding an internal exon was thus
unexpected and surprising.
Figure 1
Agarose Gel Electrophoresis of Restriction Enzyme Digests of 5' RACE Clones. DNA was extracted from 48 clones 
obtained from 5' RACE of total RNA from 10 days old larvae. The clones were digested with EcoRI and SpeI and the inserts 
separated from the cloning vector by gel electrophoresis through two-tier 1.2 % agarose gels containing ethidium bromide. 
The DNA was visualized under UV light. The horizontal arrows mark the cloning vector. The vertical arrows point to HindIII 
digests of phage lambda.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/11
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A single clone contained a 441 bp insert. The sequence of
the insert was not found in the available c241 subclone
sequences. To determine if it might be a BDNF 5' exon it
was compared with all known sequences using BLAST. A
segment of 29 nucleotides that was identical with a seg-
ment in rat exon II was found, suggesting the insert was a
5' BDNF gene exon. This segment was named highly con-
served sequence 2, or HCS2 (see table 1 – additional file
1). The exon was named exon 1a.
Exon 1a was located outside the sequenced regions of the
genomic clone c241 [27]. To identify its location in c241,
a HindIII restriction digest of c241 was subjected to south-
ern blot hybridization analysis using a probe specific for
exon 1a. A 5.7 KB HindIII fragment specifically hybridized
Figure 2
Organization of BDNF Genes. The boxes represent exons and the lines introns, 5' flanks and 3' flank. Exons containing 
highly conserved sequences (HCS) have the same colors. The positions of the mouse BDNF gene exons were taken from 
sequence posted in the NCBI databank http://www.ncbi.nlm.nih.gov/entrez/, accession AY057907. The rat exons were pub-
lished by Timmusk et al. [25] and Bishop et al. [26]. The sequences posted in the NCBI databank (Accession numbers S76799, 
S76760, S76759, S76758, S76757, X67107, X67106, X67108) were compared with the mouse and found to be >98% identical. 
Their positions in the rat gene were assumed to be identical to those of the mouse exons. The positions of the human BDNF 
gene exons were taken from the sequence posted in the NCBI databank, accession number AF411339. The pufferfish BDNF 
gene sequence was taken from the Ensembl Genome Data Resource of the Wellcome Trust Sanger Centre http://
www.sanger.ac.uk/), scaffold_551 and scaffold_1408. Exons 1b, b', 1c, and 2 of the zebrafish BDNF gene were mapped on the 
sequence of clone CH211-251J8, posted in the NCBI databank, accession number AL935207. Zebrafish and pufferfish gene 
exon sequences were >75% identical including presumptive exon 1d.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/11
Page 5 of 14
(page number not for citation purposes)
to the probe. This fragment was subcloned into the Hin-
dIII site of the EGFP vector by plus/minus green cloning.
A 2 KB region containing exon 1a was sequenced. Com-
parison of the genomic and 5' RACE sequences indicated
that the novel 5' portion of the insert was present as a con-
tinuous sequence in the genomic clone. Moreover, a clas-
sical splice donor site followed the 5' end (table 2 – see
additional file 2). The insert thus represented a 5' non-
coding exon of the zebrafish BDNF gene.
These cloning and sequencing data indicate that at least
three distinct transcripts are derived from the zebrafish
BDNF gene (figure 3).
A single 5' RACE clone did not exhibit any homology to
the mammalian or zebrafish BDNF genes. A BLAST search
identified the insert as the 5' end of β-actin mRNA.
Organization of the Zebrafish and mammalian BDNF 
Genes are similar
The locations of the exons identified by 5' RACE in the
BDNF transcription unit were mapped in three ways. First
their nucleotide sequences were compared with that of
clone CH211-251J8, which carries a 149 KB zebrafish
genomic fragment (NCBI databank accession #
AL935207). Exon 1b was found at nucleotides 1050–
1101, exon 1b' at nucleotides 2006–2200, and exon 1c at
nucleotides 6100–6397 (figure 2). Exon 1a was not
found.
Second, the nucleotide sequences were compared to
known BDNF exons by a BLAST search. A short segment
of identity was found in exon 1a with exon 2 of the
mouse, human, and rat genes, suggesting it is orthologous
to these exons, and thus should lie upstream from exon
1b (see table 1 – see additional file 1). These analyses
placed exon 1a upstream from exons 1b, b' and c and
upstream from the 5' end of clone CH211-251J8.
Third, to confirm this upstream location, and to estimate
the distance between exon 1a and 1b, long-range PCR was
done with a sense primer (ex1aP3) in exon 1a and an anti-
sense primer in exon 1b (sc1P18) using the genomic clone
c241 as a template. A PCR product of 3.2 KB was obtained
(see figure 4). No PCR product was obtained when sense
and antisense primers were switched. The PCR product
would be expected to be 2.4 if the exon 1a and 1b contain-
ing HindIII fragments were contiguous. The larger size
suggested that a 0.8 KB HindIII fragment was present
between the two. To test this possibility, the PCR product
was digested with HindIII. Three fragments were gener-
ated, indicating the presence of an interposed fragment.
Their sizes were consistent with the largest and smallest
being derived from the exon 1b and 1a containing HindIII
fragments, respectively, and the middle one being an
interposed fragment. A HindIII subclone of c241 was
found with an insert identical in size with the interposed
fragment (figure 2). The subclone was named Dex1aDS.
The insert of Dex1aDS was sequenced and its orientation
determined by PCR using either primer ex1aP3 or sc1P18
paired with a primer (Dex1aDSP1) located within
Dex1aDS.
The sequencing and PCR data and the nucleotide
sequence of clone CH211-251J8 were used to construct a
HindIII map of the zebrafish BDNF gene (see figure 5).
Figure 3
Splicing of Zebrafish BDNF Exons into Mature Transcripts. The boxes are exons and the horizontal line represents 5' 
flanks, introns, and 3' flank. Angled lines to indicate splicing into mature transcripts connect the exons. The depicted combina-
tions were identified by 5' RACE and cDNA cloning. Additional combinations may exist.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/11
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Comparison with pufferfish gene suggests existence of an 
additional exon
The pufferfish BDNF gene is located in the scaffold_551.1
contig (Ensembl). Fugu rubripes and  Danio rerio both
belong to the infraclass teleostei. The two BDNF genes can
therefore be expected to be well conserved. The nucleotide
sequences of the two genes were searched for identities
using Bestfit and Gap from the GCG sequence analysis
package. These comparisons revealed three regions in the
pufferfish gene whose nucleotide sequences were >78%
identical with exons 1a, b, and c of the zebrafish gene. The
relative positions of these exons to each other and the cod-
ing exons were identical in both genes. The distances
between these exons and their distances to the coding
exon were also very similar. An additional region of >78%
identity was found between exon 1c and the coding exon
at nucleotides 9592–9876 of the zebrafish sequence
(nucleotide numbers of clone CH211-251J8). This region
could represent exon 1d and hence might correspond to
rat and mouse exon 5. Since this exon has not yet been
cloned by 5' RACE its inclusion in figure 3 is tentative.
Collectively, the 5' RACE, mapping, PCR and sequence
comparison data suggest that the zebrafish BDNF gene
has at least 4 and possibly 5 non-coding exons if exon 1 d
is included, and that at least one transcript has 3 exons
(see figure 3).
Exons 1a and 1c contain highly conserved sequences
Nucleotide sequence analysis of the 5' RACE clones so far
identified three additional 5' exons, namely exons 1a, 1 b
and 1b'. A striking structural feature of exon 1a is a 25
nucleotide highly conserved segment (HCS2) that is iden-
tical to a segment of rat exon II (see table 1 [additional file
1] and figure 2). The function of HCS2 is unknown. This
segment is also conserved in the pufferfish genome
(scaffold_551; scaffold_1408). We previously reported
the presence of a 39 bp segment within exon 1c in which
37 bps are identical in man and fish (see table 1 – addi-
tional file 1). The significance of this highly conserved seg-
ment (HCS1) is unknown.
In contrast to exons 1a and 1c, exons 1b and 1b' exhibit
only random similarity with the known mammalian
exons. A region of high similarity was found in the puffer-
fish gene in a location expected for exon 1b. Exon 1b' dif-
fers from any mammalian counterparts in that it is an
internal non-coding exon. So far internal non-coding
exons have only been described in other neurotrophin
genes, at first in the mouse NGF gene [30,31] and subse-
quently in the NT-3 gene [32] and more recently in the
NT-4/5 gene [33].
The 5' flank of exon 1b is GC-rich and contains multiple 
Sp1 and Mef2 binding site consensus sequences
The flanking regions of exons 1a and 1b were analyzed for
potential transcription factor binding sites using the
Transfac database and search engine [34]. The flank of
exon 1b is GC-rich and contains multiple potential Sp1
binding sites close to the promoter. Two potential Mef2
sites were also found (see table 3 – additional file 3). The
nucleotide sequence is strikingly similar to that of the 5'
Figure 4
Identification of Interposed HindIII Fragment by 
Long Range PCR and Restriction Enzyme Digestion 
of HindIII Subclone of Genomic Clone c241. PCR was 
carried out using the zebrafish BDNF genomic clone c241 as 
a template. The primers were ex1aP3 and sc1P18. An aliquot 
of the PCR products (lane 1) was digested with HindIII (lane 
2). A HindIII subclone of genomic clone c241 was also 
digested with HindIII. The PCR and digestion products were 
separated by electrophoresis on a 1.2% agarose gel contain-
ing ethidium bromide. Lane 1: PCR product. Lane 2: Hin-
dIII digest of PCR product. Lane 3: HindIII digest of 
subclone. Lane 4: HindIII digest of phage lambda. Sizes of 
fragments are shown in the right hand margin.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/11
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flank of the FGFR1 gene. The FGFR1 gene is expressed in
myocytes in their terminal differentiation phase.
The 5' flank of exon 1a, in contrast, has a more classical
TA-rich promoter region, and is devoid of Sp1 and Mef2
sites (see table 4 – additional file 4).
Fusion genes containing exon 1b/b' are specifically 
expressed in skeletal muscle
To confirm that the cloned promoters were functionally
competent and to begin to identify regulatory regions
within the promoters the cloned promoters were linked to
the EGFP-F reporter (see figure 6). The fusion genes were
injected into embryos and expression examined by fluo-
rescent microscopy in live embryos.
Promoter 1b was linked to the EGFP-F reporter using a
HindIII/BamHI fragment that contained 5' flank, exons
1b and b', 3 KB of intron 1b', and the coding exon splice
acceptor site preceded by 250 nucleotides of intron 1c.
This construct was named AJ. For expression studies, the
vector sequences and all SV40 sequences except the SV40
3' UT and polyA addition site were removed by MluI
digestion followed by purification on an agarose gel.
In two series of injections 350 embryos were injected with
AJ. The 2-day survival rate was 60%. 56 of the surviving
embryos expressed the reporter 2 days after fertilization.
Over 90% of the expressing cells were skeletal muscle
cells. Expression was mostly seen in trunk muscles, rarely
close to the tail, and never in the head (figure 4). In a few
embryos AJ was also expressed in notochord and vascular
cells. In a rare embryo expression was seen in neurons and
blood cells.
To further narrow down the sequences that are responsi-
ble for expression in myocytes exon 1b was directly linked
to the reporter using a PstI site 10 nucleotides down-
stream from the transcription start site (see clone CH211-
251J8). In this construct, which was named AJ/Pst, intron
1b, exon 1b' and most of intron 1c, totalling 3.6 KB, are
eliminated. In a series of 250 injections with a survival
rate of 55% and an expression rate of 30% AJ/Pst was also
specifically expressed in myocytes (see figure 7).
Fusion genes containing exon 1a are transiently expressed 
in yolk
Promoter 1a was linked to the EGFP-F reporter in a similar
fashion (figure 6). The 5' flank extended to -3.5 KB. How-
ever, only 179 bps of intron 1a were used. Thus the total
composite intron size was 325 bps. This construct, which
was named DOA5 was injected into sets of 150 and 250
embryos. The survival rate was 45% and 55%. 40% of the
combined survivors expressed the reporter. All had an
unusual pattern of expression. There was intense labelling
of round structures of variable size and labelling intensity
by 10 h pf (see figure 8). These structures did not conform
to any cellular or subcellular shapes. They were close to
the surface of the embryos. Because of limited spatial res-
olution it was not clear whether they were in the yolk or
in cells on the surface of the embryo. These structures
tended to be present in limited sections of the embryo but
generally did not follow a specific pattern. However, in a
few embryos there were more ordered patterns. In one
embryo there was a line of labelled structures coinciding
with the embryonic midline. In the same embryo there
was an anterior semilunar patch arranged symmetrically
about the midline. By 20 h pf most of the labelled struc-
tures had moved into the embryo in various and
Figure 5
HindIII Map of Zebrafish BDNF Gene. The map is based on the nucleotide sequence of clone CH211-251J8 (NCBI data-
bank accession number AL935207) as well as restriction digest, southern blot hybridization, PCR and sequence analyses of 
c241. See results and methods for details. The boxes are exons and the line 5' flanks, introns, and 3' flank. The black vertical 
arrows mark HindIII sites. The red arrow marks the EcoRI site at the 5' end of clone CH211-251J8.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/11
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seemingly random locations. By 2 days pf only a few
remained, and by 3 days pf no labelled structures or cells
were seen in 99% of the embryos. A very rare embryo had
expression in the notochord or transient expression in
several myocytes. The same expression was found with a
construct in which the exon was directly linked to the
reporter at a BglII site. This construct has no intron.
Expression of endogenous exons is tissue-specific
The fusion genes containing exon 1b and its 5' flank were
expressed only in skeletal muscle. To determine whether
the endogenous exon were also expressed cell-specifically,
total RNA was extracted from the skeletal muscle of an
adult female and analyzed for exon 1a using RT-PCR. To
increase specificity and sensitivity, two rounds of PCR
were done with nested primers. Diluting the cDNA tem-
plate 100-fold prior to amplification with β-actin primers
checked the quality of the cDNA. β-actin mRNA was read-
ily amplified in the first round of PCR indicating the
cDNA was of good quality. Surprisingly, exon 1b could
not be detected even after two rounds of PCR (see figure
12). The primers were competent as they yielded product
when the 5'RACE clone was used as a template.
Exon 1b could be spliced directly to exon 2. The resulting
bipartite transcript would yield a PCR product of 93 bps.
No PCR products in that size-range were seen. A set of
nested antisense primers that is 300 bps further down-
stream also gave negative results. In contrast to exon 1b,
exon 1c was detected in muscle RNA after the second
round of PCR. Total RNA from whole juvenile fish was
also analyzed, as it should contain all exons that are
expressed at this stage of development. Both exon 1a and
1c were found. The amplifications with exon 1b primers
Figure 6
Expression Constructs. The constructs were assembled from cloned or amplified DNA. All junctions were sequenced to 
confirm correct assembly. The green box represents the reporter EGFP-F. The maroon box represents a 300 bp fragment of 
the zebrafish BDNF gene that begins 280 bps upstream from exon 2 and ends at nucleotide 21 of the coding exon and thus 
contains the splice acceptor site. Note that the5' exons are directly joined to reporter in the shorter constructs. All constructs 
share the 3' UT and polyadenylation signal of the IE of SV40.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/11
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yielded minor amounts of DNA that did not co-migrate
with the controls. It is possible that they represent tran-
scripts in which exon 1b is spliced to exons other than 1b'.
Discussion
The data presented in this report show that the overall
organization of the BDNF gene is similar in fish and man.
However, fish and human genes differ significantly in the
size of the transcription unit, the number of exons, and
the splicing patterns of the exons. In contrast, the
zebrafish and pufferfish BDNF genes are highly similar in
all regions that could be compared. The pufferfish gene is
flanked on the 5' side by a kinesin gene that lies 30 kb
upstream from the BDNF coding exon and on the 3' side
by a Lin7 gene, less than 5 kb downstream from the cod-
ing exon. The fish transcription unit thus appears to span
between 15 and 30 KB. In contrast, the mouse and human
genes are between 60 and 80 KB long, at least twice and
possibly four times as large. The difference in size is due
to much larger introns in the mammalian genes.
A second difference between fish and mammalian genes is
the generation of a tripartite transcript from the fish gene.
Such tripartite transcripts have not yet been described in
mouse, rat, or human. A more thorough examination of
all human transcripts may eventually uncover tripartite
messages in the human.
A third difference between fish and mammalian genes is
the much greater diversity of exons in the human gene,
even when compared with the mouse. However, neither
in the zebrafish nor the mouse has an exhaustive search
for all possible exons been conducted yet. We have
recently found additional exons in a second round of
5'RACE. However, they have not yet been sequenced or
mapped on the transcription unit.
The 5' exons of the rat and mouse genes and their associ-
ated promoters are expressed in a tissue and cell-specific
manner [25]. The data presented here as well as data pre-
sented in a previous report [35] indicate that the zebrafish
Figure 7
Expression of promoter 1b fusion construct in myocytes. The exon 1b/1b' constructs shown in the lower panel of fig-
ure 6 were injected into zebrafish embryos at the 1–4 blastomere stages. Live embryos and larvae were observed at various 
developmental stages under a fluorescent microscope to detect expression of the EGFP-F reporter. Panel A: 2 days old 
embryo. Panels B–D: 3 days old larvae. The arrow in panel D points to a labeled myocyte.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/11
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BDNF gene promoters are also expressed in a tissue-spe-
cific manner. When linked to the EGFP-F reporter exon 1b
was primarily expressed in skeletal muscle cells. Visible
expression did not start until the myocytes exhibited stri-
ations. However, there may a significant time lag between
onset of transcription of the transfected DNA, EGFP-F
aggregation and insertion into the membrane. Both are
required for efficient fluorescence. Thus, the precise onset
of transcription of the transgene is uncertain. It is also pos-
sible that the EGFP-F reporter is quite stable and persists
beyond a period of transient transcription.
Figure 8
Expression of promoter 1a fusion construct: labelling of yolk platelets. The exon 1a constructs shown in the upper 
panel of figure 6 were injected into zebrafish embryos at the 1–4 blastomere stages. Live embryos were observed at various 
stages of development under a fluorescent microscope to detect the EGFP-F reporter. Panel A: low magnification view of 
multiple embryos 10 hrs after fertilization (1–5 somite stages). The speckles are yolk platelets labeled by EGFP-F. They are 
slightly out of focus due to bulk motion of the water in which the embryos are suspended. The arrow points to a developing 
embryo on top of the yolk. The embryo exhibits background fluorescence. Panel B: A 10 hrs old embryo in which some of 
the yolk platelets line up with the developing trunk and head. The arrow points to the trunk. The head, to the left, is out of 
focus. Panel C: 10 hrs old embryo. The line is not coincident with the body axis in this embryo. Panel C: 2 days old embryo. 
Some platelets remain in the yolk. The arrow points to a platelet in the trunk.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/11
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The exclusive expression of the promoter 1b construct in
skeletal muscle differs markedly from the previously
reported expression of a promoter 1c construct [27]. The
previously tested reporter 1c construct was identical to the
promoter 1b construct injected here except for the pro-
moter sequences. It was expressed in a number of cell
types including notochord, epithelial and endothelial
cells, and skeletal muscle.
The 5' flank of exon 1b was searched with TransFac for
potential transcription factor binding sites [34]. Potential
binding sites for three transcription factors that have been
shown to play key roles in muscle gene expression were
found, Sp-1, Mef2 and SRF [36]. Four potential Sp1 and
two Mef2 bindings sites were found within 300 bps of the
transcription start. A potential SRF binding site is also
close to the transcription start site. Farther upstream two
AP-1 sites were found. These Sp-1 and Mef2 sites may play
a role in muscle expression of the BDNF gene. The proxi-
mal 5' flank of the FGFR1 gene has a similar clustering of
SP-1, Mef2, and SRF sites [36]. The FGFR1 gene is
expressed in terminally differentiated muscle, although at
a lower level than in proliferating myoblasts [36]. The
expression depends on Sp-1 sites in the proximal pro-
moter and the binding of Sp-1 and Sp-3 to these sites. The
absence of Sp-1 and Sp-3 from fully differentiated myo-
cytes may explain the down-regulation in terminally dif-
ferentiated muscle.
Unexpectedly, RT-PCR did not detect exon 1b in total
RNA extracted from skeletal muscle of an adult female
(see figure 9). It is possible that exon 1b is expressed in
skeletal myoblasts only transiently during the period of
innervation by primary and secondary motor neurons. We
did not assay RNA from these early stages of development.
It is also possible that exon 1b is expressed primarily in
proliferating myoblasts. The expression in skeletal
myocytes observed in the reported experiments could rep-
resent persistence of the EGFP-F reporter protein past the
time of downregulation of transcription in myocytes. Or
our construct could lack a suppressor that turns the
endogenous promoter off in terminally differentiated and
innervated myocytes. It is also possible that our construct
is expressed ectopically. However, the similarity of its 5'
flank with that of the FGFR1 gene is striking. A more
detailed analysis of the time course of expression of the
endogenous gene and cellular localization of BDNF tran-
scripts in muscle is needed to address these possibilities.
In contrast to the situation with exon 1b, exon 1c was
detected by RT-PCR in adult female muscle RNA (see fig-
ure 9). The RT-PCR data do not identify the cells that
express exon 1c. Muscle contains blood vessels and mixed
nerves. Endothelial cells are known to express BDNF [37],
and so do Schwann cells [38]. These cells may contribute
to the exon 1c transcripts. Is exon 1c expressed in myo-
cytes? The RT-PCR data strongly suggest so. In addition, a
construct that is driven by the exon 1c promoter is
expressed in various types of muscle cells [27]. However,
it is also expressed in a number of non-muscle cells. Thus,
its expression is much broader than the exclusive muscle
expression of the exon 1b construct. When the exon 1c
construct was extended in the 5' direction to include exon
1b and its flank, expression was still broad (data not
shown, manuscript in preparation). The Sp1 and Mef2
elements thus are not capable of suppressing expression
in other cell types.
It should be noted that both the exon 1b and exon 1c
expression constructs contained the SV40 IEG 3'UT and
polyadenylation signals downstream from the EGFP-F
reporter rather than BDNF sequences (see figure 6). It is
becoming clear that their presence affects expression
(manuscript in preparation). However, their effect may be
quantitative rather than qualitative. In any event, exon 1c
is the only exon that was detected in adult female muscle
by RT-PCR. Exon 1b appears to play a more limited role
during development, and possibly in muscle injury and
regeneration.
Figure 9
Expression of BDNF 5' exons in juvenile zebrafish 
and skeletal muscle of adult female zebrafish. Total 
RNA was extracted from two whole juvenile zebrafish and 
skeletal muscle of an adult female zebrafish. The RNA was 
analyzed by two rounds of nested RT-PCR for the presence 
of exons 1a, 1b/b' and 1c. Both outside and inside primers 
spanned at least one intron. An aliquot of each cDNA prepa-
ration was diluted 1:100 and amplified with beta-actin prim-
ers to assess the quality of the cDNA preparations. The 
beta-actin primers span at least one intron. The 5' RACE 
clones were used as control templates and size markers. 
Amplified DNA was separated according to size by electro-
phoresis on a 1.8% agarose gel containing ethidium and visu-
alized under UV light.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/11
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The exon 1a construct was not expressed in any identifia-
ble embryonic or larval cells at the 1-somite stage yet there
was intense labelling of yolk platelets. The platelets are
close to the surface. They are congregated preferentially
near the midline. It is not clear whether the platelets
become labelled in the yolk or within cells. Their location
close to the surface suggests they become labelled in the
yolk syncitial layer (YSL). The YSL begins to form at the
1k-cell stage, or 3 h after fertilization, when transcription
of zygotic genes begins. By the dome stage the YSL has
completely covered the yolk cell and effectively separates
the embryo from the yolk cell. The peripheral blastomeres
of the YSL appear to maintain cytoplasmic bridges with
the yolk cell. These peripheral blastomeres may continue
to take up platelets. They must also transcribe the exon 1a
construct. This possibility is consistent with our previous
in situ hybridization analyses, which revealed BDNF
expression in the peripheral YSL [35]. Some of the labeled
platelets end up in cells of the embryo and persist up to 2
days of development. These platelets must represent the
earliest onset of transcription of the injected construct,
possibly at the onset of zygotic gene transcription.
It is not clear why this particular construct consistently
and strongly labels yolk platelets. We routinely get expres-
sion of other constructs in the yolk of a small number of
embryos, presumably when there is unintended injection
or leakage into the yolk. However, in all these embryos
there is diffuse labeling of the membrane of the yolk cell
rather than labeling of platelets. Since they all encode the
same reporter and share the same 3' UT, the difference
must originate from the non-coding 5' regions of the con-
struct, either the 5' flank or 5' UT.
Conclusions
The zebrafish BDNF gene is much more compact than the
mammalian gene and rivals in compactness that of the
vertebrate with the smallest known genome, the puffer
fish. The more compact size makes the zebrafish more
amenable to comprehensive molecular genetic analysis
than the mammalian gene. The zebrafish has multiple dif-
ferentially regulated promoters and 5' exons like its mam-
malian counterpart. Two of the four presently known 5'
exons contain conserved segments that are identical in
fish and man. The promoter containing a segment identi-
cal to rat exon II is transiently expressed in the yolk synci-
tial layer. The remaining two exons are novel and generate
a tripartite transcript. The novel promoter is specifically
expressed in myocytes of transfected embryos but the
endogenous exon is not expressed in adult female muscle.
The cloned BDNF gene and knowledge of its organization
are invaluable tools for a future genetic analysis of the reg-
ulation of BDNF gene expression.
Methods
5' RACE
Amplified cDNA was generated using the Invitrogen Gen-
eRacer kit according to the manufacturer's directions
http://www.invitrogen.com. The template for cDNA
preparation was total RNA extracted from 10 days old lar-
vae using the guanidine thiocyanate method. cDNA was
generated using random hexamer oligonucleotides. The
cDNA was amplified with the GeneRacer primer and a
BDNF primer, P1, complementary to 18 nucleotides near
the 5' end of the coding exon. Half-nested PCR was then
performed using the internal 5' GeneRacer primer and P1.
The amplified cDNA was cloned using the Invitrogen
TOPO Cloning kit. DNA was extracted from individual
clones. The inserts were released by EcoRI and SpeI diges-
tion and sized using agarose gel electrophoresis. Inserts
between 0.200 and 1.5 KB were seen in 48 digests. The
inserts of 12 clones were sequenced.
Sequencing of Genomic DNA and Identification of Exons
The previously identified genomic BDNF clone [27] was
digested with HindIII and HindIII fragments subcloned
into the HindIII site of pEGFP. BDNF exon-containing
subclones were identified by dot-blot hybridization using
digoxigenin-labelled probes prepared from 5' RACE
clones by PCR. The exon-containing regions of hybridiz-
ing subclones were sequenced and the genomic sequences
compared with the cDNA sequences to identify transcrip-
tion start sites and exon/intron junctions.
RT-PCR
Total RNA was extracted from two juvenile zebrafish and
skeletal muscle of a single adult female using the method
of Chomczynski [39]. The integrity of the RNA was
checked by agarose gel electrophoresis. Approximately 1
µg of total RNA was reverse transcribed using random hex-
amers for priming of murine Maloney virus reverse tran-
scriptase. Aliquots of the samples were amplified with
nested BDNF exon-specific primers in two rounds of
amplification. β-actin primers were used as internal qual-
ity controls. The amplified DNA was subjected to agarose
gel electrophoresis.
Oligonucleotide Primer Sequences
P1: ATAGTAACGAACAGGATG
Dex1aDS1: TAGCTGTCATTCTCGTCA
Sc1P18: TTCCCAGAGGAACTCAGC
ex1aP3: GCACTTTGGACAGAGGCABMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/11
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Exon 1a nested
Outside pair: GCACTTTGGACAGAGGCA/ATAGTAAC-
GAACAGGATG
Inside pair: GGAGTCGTTGAACGCTGC/GTCTACCGGT-
CACTCTTCTAACCTGTTG
Exon 1b nested
Outside pair: ACATGGACTGAGGAGTAG/ATAGTAAC-
GAACAGGATG
Inside pair: TCAATAACAAATCTGAGC/GTCTACCGGT-
CACTCTTCTAACCTGTTG
Exon 1c nested
Outside pair: CTCAATGCGCACTAC/ATAGTAAC-
GAACAGGATG
Inside pair: GCTCAGTCATGGGAGTCC/GTCTACCGGT-
CACTCTTCTAACCTGTTG
β-actin: CAACGGCTCCGGCATGTG/TGCCAGGGTACAT-
GGTGG
Construction of Fusion Genes
Starting materials were the previously cloned genomic
subclones and a plasmid carrying EGFP-F (pEGFP-F from
Clontech, Palo Alto, CA). EGFP-F is a derivative of GFP
that exhibits enhanced fluorescence and possesses a far-
nesylation signal at the COOH-terminal. The farnesyla-
tion signal is derived from the src  protein. Once
farnesylated EGFP-F becomes anchored in the cell mem-
brane. Standard methods of restriction enzyme digestion
and ligation of selected fragments were applied to gener-
ate the various expression constructs. Junctions of heterol-
ogous fragments were sequenced to confirm correct
construction of fusion genes.
Preparation of DNA And Microinjection of Embryos
Plasmids were digested with restriction enzymes to
remove SV40 enhancers and other vector sequences. The
desired restriction fragments were purified by agarose gel
electrophoresis. DNA was dissolved in 100 mM KCl at a
concentration of 10–50 µg/ml. Phenol red was added to
visualize injected DNA solution. DNA was injected into a
blastomere or into the cytoplasmic stream below the blas-
tomere(s) at the 1–8 cell stages. Embryos were enzymati-
cally dechorionated with Pronase and extensively washed
in embryo medium prior to injection Embryo medium =
13 mM NaCl; 4.2 mM NaHCO3; 0.54 mM KCl; 0.025 mM
Na2HPO4; 0.044 mM KH2PO4; 1.3 mM CaCl2; 1 mM
MgSO4). Embryos were injected and maintained for 14
hours post fertilization on a bed of 0.7% agarose in
embryo medium. Subsequently they were placed into
deionized water in clear plastic dishes for observation
with a Zeiss AxioVert 200 M fluorescent microscope or
further growth. Pictures were taken with a digital camera
and acquired with the AxioVision software package, ver-
sion 3.0.6. The The images were processed with Power-
Point and Adobe PhotoDeluxe Business Edition.
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